Remove Cardiomyopathy Remove Heart Transplant Remove Outcomes
article thumbnail

Phenotypes in Arrhythmogenic Cardiomyopathy

All About Cardiovascular System and Disorders

Arrhythmogenic Cardiomyopathy was better known as Arrhythmogenic Right Ventricular Dysplasia or ARVD and sometimes as Arrhythmogenic Right Ventricular Cardiomyopathy or ARVC earlier. A study published in JACC has compared the phenotypic expression and clinical outcomes in patients with arrhythmogenic cardiomyopathy [2].

article thumbnail

Case report of belt electrode-skeletal muscle electrical stimulation for acute heart failure with severe obesity: a novel therapeutic option for acute phase rehabilitation

Frontiers in Cardiovascular Medicine

Background Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited.

article thumbnail

Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme

Circulation: Heart Failure

BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups. 2.58];P=0.94; congenital heart disease, 1.82 [95% CI, 0.78–4.26];P=0.17).

article thumbnail

Long?term outcome after upgrade to cardiac resynchronization therapy: A propensity score?matched analysis

European Journal of Heart Failure

However, data on long-term outcome after upgrade to CRT are scarce. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. vs. 28.8%, p  < 0.001), more often had ischeemic cardiomyopathy (49.8% ml/min/1.73 m ml/min/1.73 m 76.5], p  < 0.001).

article thumbnail

Using Stem Cell-derived Heart Muscle Cells to Advance Heart Regenerative Therapy

DAIC

The highly positive outcomes observed in primate models highlight the potential of this strategy. Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state. We are already employing the same cardiac spheroids on patients with ischemic cardiomyopathy,” comments Asst.

article thumbnail

A teenager with chest pain, a troponin below the limit of detection, and "benign early repolarization"

Dr. Smith's ECG Blog

No family history of sudden cardiac death, cardiomyopathy, premature CAD, or other cardiac issues. Pattern consistent with Takotsubo's cardiomyopathy." He was readmitted a few weeks later for a heart failure exacerbation, diuresed, and discharged again. She died before she could get a heart transplant.

article thumbnail

RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type

DAIC

Gregg Stone, MD “When you examine the outcomes in patients with heart failure across a broad range of left ventricular ejection fraction, the Ventura interatrial shunt was extremely safe but did not improve outcomes compared with no treatment. There was a tremendous placebo effect,” he said.